Sirtuin 6 Attenuates Angiotensin II-induced Vascular Adventitial Aging in Rat Aortae by Suppressing the NF-κB Pathway

Overview

Journal Hypertens Res

Specialty Cardiology & Vascular Diseases

Date 2021 Mar 3

PMID 33654247

Citations 8

Authors

Xiaoqian Liu

Dongyang Jiang

Wen Huang

Peixiu Teng

Hui Zhang

Chuanqiao Wei

Xiaowen Cai

Ying Liang

Affiliations

Soon will be listed here.

Abstract

Adventitia-induced vascular remodeling plays an important role in vascular aging. However, the mechanism remains unclear. In this study, we found that sirtuin 6 (SIRT6) expression was downregulated in the aortae of aged rats compared with those of young rats. Adventitial fibroblasts (AFs) were isolated and cultured from rat aortae to clarify the relationship between SIRT6 expression and vascular aging. Lentivirus-mediated SIRT6 knockdown promoted the aging phenotype in AFs, affecting proliferation, collagen secretion, migration, and α-smooth muscle actin expression. Moreover, angiotensin II (Ang II) decreased SIRT6 expression, activated the NF-κB pathway, and led to vascular aging. The NF-κB pathway inhibitor BAY 11-7082 reduced Ang II-induced nuclear translocation of the NF-κB p65 subunit and other effects of Ang II, such as AF proliferation, collagen secretion, and migration. Mechanistically, SIRT6 suppression increased acetyl-NF-κB p65 (Lys310) expression and NF-κB transcriptional activity in SIRT6-knockdown AFs. SIRT6 could directly bind to the p65 subunit and attenuate Ang II-induced NF-κB activation and vascular aging. In summary, this study was the first to correlate SIRT6 expression and adventitia-induced vascular senescence. SIRT6 maybe a biomarker of vascular aging, and activating SIRT6 maybe a therapeutic strategy for delaying vascular aging.

Citing Articles

Unraveling Elastic Fiber-Derived Signaling in Arterial Aging and Related Arterial Diseases.

Wang M, McGraw K, Monticone R, Pintus G Biomolecules. 2025; 15(2).

PMID: 40001457 PMC: 11853455. DOI: 10.3390/biom15020153.

NAD: A key metabolic regulator with great therapeutic potential for myocardial infarction via Sirtuins family.

Yao W, Pei Z, Zhang X Heliyon. 2023; 9(11):e21890.

PMID: 38027748 PMC: 10663897. DOI: 10.1016/j.heliyon.2023.e21890.

The many faces of SIRT6 in the retina and retinal pigment epithelium.

Cheng J, Keuthan C, Esumi N Front Cell Dev Biol. 2023; 11:1244765.

PMID: 38016059 PMC: 10646311. DOI: 10.3389/fcell.2023.1244765.

Sirtuin 6-A Key Regulator of Hepatic Lipid Metabolism and Liver Health.

Dong X Cells. 2023; 12(4).

PMID: 36831330 PMC: 9954390. DOI: 10.3390/cells12040663.

Update on Hypertension Research in 2021.

Mogi M, Maruhashi T, Higashi Y, Masuda T, Nagata D, Nagai M Hypertens Res. 2022; 45(8):1276-1297.

PMID: 35790879 PMC: 9255494. DOI: 10.1038/s41440-022-00967-4.

References

Ungvari Z, Kaley G, de Cabo R, Sonntag W, Csiszar A . Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci. 2010; 65(10):1028-41. PMC: 2950814. DOI: 10.1093/gerona/glq113. View

Nakamura T, Saito Y, Ohyama Y, Masuda H, Sumino H, Kuro-O M . Production of nitric oxide, but not prostacyclin, is reduced in klotho mice. Jpn J Pharmacol. 2002; 89(2):149-56. DOI: 10.1254/jjp.89.149. View

Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T . Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997; 390(6655):45-51. DOI: 10.1038/36285. View

Haurani M, Pagano P . Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: bellwether for vascular disease?. Cardiovasc Res. 2007; 75(4):679-89. DOI: 10.1016/j.cardiores.2007.06.016. View

Sartore S, Chiavegato A, Faggin E, Franch R, Puato M, Ausoni S . Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ Res. 2001; 89(12):1111-21. DOI: 10.1161/hh2401.100844. View

Dzau V, Braun-Dullaeus R, Sedding D . Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med. 2002; 8(11):1249-56. DOI: 10.1038/nm1102-1249. View

Sun H, Wu Y, Fu D, Liu Y, Huang C . SIRT6 regulates osteogenic differentiation of rat bone marrow mesenchymal stem cells partially via suppressing the nuclear factor-κB signaling pathway. Stem Cells. 2014; 32(7):1943-55. DOI: 10.1002/stem.1671. View

Kanfi Y, Naiman S, Amir G, Peshti V, Zinman G, Nahum L . The sirtuin SIRT6 regulates lifespan in male mice. Nature. 2012; 483(7388):218-21. DOI: 10.1038/nature10815. View

Mostoslavsky R, Chua K, Lombard D, Pang W, Fischer M, Gellon L . Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell. 2006; 124(2):315-29. DOI: 10.1016/j.cell.2005.11.044. View

10.

Gertler A, Cohen H . SIRT6, a protein with many faces. Biogerontology. 2013; 14(6):629-39. DOI: 10.1007/s10522-013-9478-8. View

11.

Yang Y, Tian T, Wang Y, Li Z, Xing K, Tian G . SIRT6 protects vascular endothelial cells from angiotensin II-induced apoptosis and oxidative stress by promoting the activation of Nrf2/ARE signaling. Eur J Pharmacol. 2019; 859:172516. DOI: 10.1016/j.ejphar.2019.172516. View

12.

He Y, Xiao Y, Yang X, Li Y, Wang B, Yao F . SIRT6 inhibits TNF-α-induced inflammation of vascular adventitial fibroblasts through ROS and Akt signaling pathway. Exp Cell Res. 2017; 357(1):88-97. DOI: 10.1016/j.yexcr.2017.05.001. View

13.

Kida Y, Goligorsky M . Sirtuins, Cell Senescence, and Vascular Aging. Can J Cardiol. 2016; 32(5):634-41. PMC: 4848124. DOI: 10.1016/j.cjca.2015.11.022. View

14.

Cardus A, Uryga A, Walters G, Erusalimsky J . SIRT6 protects human endothelial cells from DNA damage, telomere dysfunction, and senescence. Cardiovasc Res. 2012; 97(3):571-9. PMC: 3567786. DOI: 10.1093/cvr/cvs352. View

15.

Kawahara T, Michishita E, Adler A, Damian M, Berber E, Lin M . SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell. 2009; 136(1):62-74. PMC: 2757125. DOI: 10.1016/j.cell.2008.10.052. View

16.

Wang W, Yan C, Zhang J, Lin R, Lin Q, Yang L . SIRT1 inhibits TNF-α-induced apoptosis of vascular adventitial fibroblasts partly through the deacetylation of FoxO1. Apoptosis. 2013; 18(6):689-701. DOI: 10.1007/s10495-013-0833-7. View

17.

Dong X, Ye X, Song N, Zhao J, Di B, Peng F . Urotensin II promotes the production of LTC4 in rat aortic adventitial fibroblasts through NF-κB-5-LO pathway by p38 MAPK and ERK activations. Heart Vessels. 2012; 28(4):514-23. DOI: 10.1007/s00380-012-0291-0. View

18.

Zhang J, Fang C, Qu M, Wu H, Wang X, Zhang H . CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents. Front Pharmacol. 2018; 9:1042. PMC: 6144529. DOI: 10.3389/fphar.2018.01042. View

19.

Suzuki A, Osanai T, Tanaka M, Tomita H, Magota K, Okumura K . Coupling factor 6 attenuates CXCR4 expression through the HIF-1α and c-Src pathways and promotes endothelial apoptosis and inflammation. Hypertens Res. 2014; 37(8):708-15. DOI: 10.1038/hr.2014.65. View

20.

Yang D, Xiao C, Long F, Wu W, Huang M, Qu L . Fra-1 plays a critical role in angiotensin II-induced vascular senescence. FASEB J. 2019; 33(6):7603-7614. DOI: 10.1096/fj.201801671RRRR. View